Impact of Hyperoncotic Albumin to Support Blood Loss Replacement

Clinical trial NCT03848507 · COMPLETED

Trial details

NCT number: NCT03848507
Sponsor: Insel Gruppe AG, University Hospital Bern
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Blood Loss, Surgical Fluid Retention

Start date: 2019-03-18
Primary completion: 2020-02-12
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.